The Use of a Combination of Vaccinium Macracarpon, Lycium barbarum L. and Probiotics (Bifiprost®) for the Prevention of Chronic Bacterial Prostatitis: A Double-Blind Randomized Study.
- 2019
- RCT · n = 120
- Urologia internationalis 103(4)
- Francesco Chiancone
- Maurizio Carrino
- Clemente Meccariello
- Luigi Pucci
- Maurizio Fedelini
- Paolo Fedelini
- PubMed: 31527377
- DOI: 10.1159/000502765
- High evidence
- Large Human Trial
- Clinical
After 12 weeks of treatment, the mean NIH-CPSI score was reduced in both groups compared with baselines, but no significant differences were seen between the Group A and Group B. On the contrary, we observed a significant difference in the mean NIH-CPSI score between the 2 groups at 24 and 36 weeks.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 320 mg/day